Sfoglia per Rivista JAMA ONCOLOGY
Improving the Propranolol Treatment of Melanoma-Reply.
2018 Benemei, Silvia; Geppetti, Pierangelo; De Giorgi, Vincenzo*
Integrating Oncology Lessons Across Tumor Types From Kidney to Prostate-A Good-Risk Shift
2025 Roviello, Giandomenico
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab. A Post Hoc Analysis of the PETACC-8 Trial
2016 Taieb, J; Zaanan, A; Le Malicot, K; Julié, C; Blons, H; Mineur, L; Bennouna, J; Tabernero, J; Mini, E; Folprecht, G; Van Laethem, Jl; Lepage, C; Emile, Jf; Laurent-Puig, P
Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study
2018 De Giorgi, Vincenzo; Grazzini, Marta; Benemei, Silvia; Marchionni, Niccolò; Botteri, Edoardo; Pennacchioli, Elisabetta; Geppetti, Pierangelo; Gandini, Sara
Risk of Second Cancer in Erdheim-Chester Disease
2025 Pegoraro, Francesco; Peyronel, Francesco; Errahmani, Mohamed-Yassir; Catamerò, Francesco; Papo, Matthias; Cohen-Aubart, Fleur; Tesi, Michelangelo; Razanamahery, Jerome; Charlotte, Frederic; Le Scornet, Tanguy; Aouba, Achille; Roos-Weil, Damien; Tondo, Annalisa; Sieni, Elena; Amoura, Zahir; Emile, Jean-François; Annesi-Maisano, Isabella; Vaglio, Augusto; Haroche, Julien
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.
2018 Zaanan, A; Shi, Q; Taieb, J; Alberts, Sr; Meyers, Jp; Smyrk, Tc; Julie, C; Zawadi, A; Tabernero, J; Mini, E; Goldberg, Rm; Folprecht, G; Van Laethem JL, ; Le Malicot, K; Sargent, Dj; Laurent-Puig, P; Sinicrope, F. A.
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial
2015 Pardanani, Animesh; Harrison, Claire; Cortes, Jorge E; Cervantes, Francisco; Mesa, Ruben A; Milligan, Donald; Masszi, Tamás; Mishchenko, Elena; Jourdan, Eric; Vannucchi, Alessandro M; Drummond, Mark W; Jurgutis, Mindaugas; Kuliczkowski, Kazimierz; Gheorghita, Emanuil; Passamonti, Francesco; Neumann, Frank; Patki, Abhay; Gao, Guozhi; Tefferi, Ayalew
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma
2019 Mathilde Sibon; Frédérique Tissier; Sébastien Gaujoux; Bertrand Dousse; Silviu Sbiera; Cristina L. Ronchi; Matthias Kroiss; Esther Korpershoek; Ronald De Krijger; JensWaldmann; Marcus Quinkler; Magalie Haissaguerre; Antoine Tabarin; Olivier Chabre; Michaela Luconi; Massimo Mannelli; Lionel Groussin; Xavier Bertagna; Eric Baudin; Laurence Amar; Joel Coste; Felix Beuschlein; Jérôme Bertherat
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Improving the Propranolol Treatment of Melanoma-Reply. | 2018 | Benemei, Silvia; Geppetti, Pierangelo; De Giorgi, Vincenzo* | |
| Integrating Oncology Lessons Across Tumor Types From Kidney to Prostate-A Good-Risk Shift | 2025 | Roviello, Giandomenico | |
| Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab. A Post Hoc Analysis of the PETACC-8 Trial | 2016 | Taieb, J; Zaanan, A; Le Malicot, K; Julié, C; Blons, H; Mineur, L; Bennouna, J; Tabernero, J; Mini, E; Folprecht, G; Van Laethem, Jl; Lepage, C; Emile, Jf; Laurent-Puig, P | |
| Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study | 2018 | De Giorgi, Vincenzo; Grazzini, Marta; Benemei, Silvia; Marchionni, Niccolò; Botteri, Edoardo; Pennacchioli, Elisabetta; Geppetti, Pierangelo; Gandini, Sara | |
| Risk of Second Cancer in Erdheim-Chester Disease | 2025 | Pegoraro, Francesco; Peyronel, Francesco; Errahmani, Mohamed-Yassir; Catamerò, Francesco; Papo, Matthias; Cohen-Aubart, Fleur; Tesi, Michelangelo; Razanamahery, Jerome; Charlotte, Frederic; Le Scornet, Tanguy; Aouba, Achille; Roos-Weil, Damien; Tondo, Annalisa; Sieni, Elena; Amoura, Zahir; Emile, Jean-François; Annesi-Maisano, Isabella; Vaglio, Augusto; Haroche, Julien | |
| Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials. | 2018 | Zaanan, A; Shi, Q; Taieb, J; Alberts, Sr; Meyers, Jp; Smyrk, Tc; Julie, C; Zawadi, A; Tabernero, J; Mini, E; Goldberg, Rm; Folprecht, G; Van Laethem JL, ; Le Malicot, K; Sargent, Dj; Laurent-Puig, P; Sinicrope, F. A. | |
| Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial | 2015 | Pardanani, Animesh; Harrison, Claire; Cortes, Jorge E; Cervantes, Francisco; Mesa, Ruben A; Milligan, Donald; Masszi, Tamás; Mishchenko, Elena; Jourdan, Eric; Vannucchi, Alessandro M; Drummond, Mark W; Jurgutis, Mindaugas; Kuliczkowski, Kazimierz; Gheorghita, Emanuil; Passamonti, Francesco; Neumann, Frank; Patki, Abhay; Gao, Guozhi; Tefferi, Ayalew | |
| Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma | 2019 | Mathilde Sibon; Frédérique Tissier; Sébastien Gaujoux; Bertrand Dousse; Silviu Sbiera; Cristina L. Ronchi; Matthias Kroiss; Esther Korpershoek; Ronald De Krijger; JensWaldmann; Marcus Quinkler; Magalie Haissaguerre; Antoine Tabarin; Olivier Chabre; Michaela Luconi; Massimo Mannelli; Lionel Groussin; Xavier Bertagna; Eric Baudin; Laurence Amar; Joel Coste; Felix Beuschlein; Jérôme Bertherat |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile